- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01059032
Enhancement and Restoring of Low Dose Abdominal CT Images
June 1, 2015 updated by: Lars Borgen
Enhancement and Restoring of Low Dose Abdominal CT Images by a Novel Adaptive Nonlinear 3D Post Processing Filter - a Prospective Blinded Interventional Study
Through the rapid growth of multislice Computer Tomography (CT) imaging, radiation protection has become a major issue in the radiological community.
Optimizing CT scanning is a key task when keeping the radiation doses as low as reasonable achievable (the ALARA principle).
Post processing filters can improve and restore grainy and noisy low dose CT images by enhancing structure and reducing image noise.
In our study of 10 patients, the investigators perform a preliminary evaluation of a novel post processing filter, which does picture element correlations in all three spatial dimensions.
By comparing normal dose pictures with unprocessed low-dose pictures and pictures processed with two dimentional (2D) and three dimentional (3D) filters,the investigators will be able to assess the possible clinical value of the 3D filter.
This project is collaboration between Buskerud Hospital (BU), Buskerud University College, Norwegian Radiation Protection Authority (NRPA) and Center for Medical Image Science and Visualization (CMIV).
The project is part of the PhD of Lars Borgen.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
12
Phase
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Drammen, Norway, 3014
- Buskerud Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
60 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Outpatients, Male or female,Age above 60 years, Referred to our department for an abdominal CT with intravenous contrast.
Exclusion Criteria:
- Abdominal diameter less than 80cm or larger than 100cm, Gross pancreatic pathology, Gross anatomic anomalies in the investigated region, Intolerance of intravenous contrast
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Unenhanced images
|
|
|
Other: Enhanced images
|
Using a 3 dimentional post processing filter
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Rating of image quality
Time Frame: 3-6 months
|
3-6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2009
Primary Completion (Actual)
December 1, 2010
Study Completion (Actual)
December 1, 2011
Study Registration Dates
First Submitted
January 21, 2010
First Submitted That Met QC Criteria
January 28, 2010
First Posted (Estimate)
January 29, 2010
Study Record Updates
Last Update Posted (Estimate)
June 2, 2015
Last Update Submitted That Met QC Criteria
June 1, 2015
Last Verified
November 1, 2009
More Information
Terms related to this study
Other Study ID Numbers
- 15017044793
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Radiation Protection
-
North Texas Veterans Healthcare SystemCompletedRadiation Protection | Radiation MonitoringUnited States
-
Baylor Research InstituteNot yet recruitingRadiation ProtectionUnited States
-
University of PennsylvaniaCanon Medical Systems, USARecruitingImage Enhancement | Radiation ProtectionUnited States
-
BayerCompleted
-
Democritus University of ThraceCompleted
-
Seoul National University HospitalCompletedMyocardial ProtectionKorea, Republic of
-
Bispebjerg HospitalCompleted
-
University of Michigan Rogel Cancer CenterNot yet recruitingSun ProtectionUnited States
-
Hospital Nossa Senhora da ConceicaoNot yet recruitingMyocardial ProtectionBrazil
Clinical Trials on Using a 3 dimentional post processing filter
-
Methodist Health SystemCompleted
-
Instituto Traumatologico Dr. Teodoro Gebauer WeisserUnknown
-
Assistance Publique - Hôpitaux de ParisURC-CIC Paris Descartes Necker CochinRecruitingGenital Diseases, Female | Hyperemesis Gravidarum | Ectopic Pregnancy | Abortion, Missed | Uncertain Viability of PregnancyFrance
-
Benaroya Research InstituteRecruitingBenign Prostatic Hypertrophy (BPH) | Lower Urinary Track SymptomsUnited States
-
Memorial Sloan Kettering Cancer CenterUniversity of Pisa; University of California, San Francisco; The Champalimaud...Active, not recruitingMelanoma | Sarcoma | Ovarian Cancer | Bone | Soft Tissue | Lymph Nodes | CNS-Spinal CD/MEMBR, NOSUnited States, Italy, Portugal
-
University of RochesterBiosense Webster, Inc.TerminatedHeart Failure With Preserved Ejection FractionUnited States
-
Ain Shams UniversityCompletedMaxillary Expansion | Bilateral Cleft Lip and PalateEgypt
-
Centre Jean PerrinCompleted
-
Merve YETİMOĞLUKaradeniz Technical UniversityRecruiting
-
Memorial Sloan Kettering Cancer CenterSamus TherapeuticsActive, not recruitingNon-Hodgkin's Lymphoma | Myeloma | Active Solid MalignancyUnited States